In this episode, Anne MacNeil and Karina Lahnakoski discuss the latest trends and updates from Health Canada, focusing on the impact of government changes, drug shortages, new guidance documents, inspection trends, and the role of AI in the pharmaceutical industry. They also highlight the importance of addressing nitrosamines in drug products and the need for compliance with upcoming regulations.